Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro does not have to be injected at exactly the same clock time every week, but consistency matters. The licensed schedule is once weekly, and taking each dose within a stable, predictable window helps you build a routine that keeps the medicine working as intended. That said, Mounjaro is a prescription-only medicine (tirzepatide), and your prescriber decides the schedule that suits your circumstances. This page covers what the clinical guidance says, how much flex is built in, and what to do if your usual day shifts.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The short answer is no. Mounjaro is designed as a once-weekly medicine, and the guidance focuses on the day rather than the hour. The NHS tirzepatide information page confirms that you should take Mounjaro on the same day each week, but there is no requirement to administer it at a specific time of day. Morning, evening, before a meal or after one, none of that changes how the medicine behaves in your body.
Tirzepatide's half-life is around five days, which means levels in your bloodstream change very gradually. A few hours' drift on your usual day will not cause a clinical problem. What does matter is the gap between doses: each injection should be roughly seven days after the last.
Where people often trip up is confusing time-of-day precision with day-of-week consistency. The latter is genuinely useful, mostly as a memory aid. Choosing a day that anchors to something regular in your week (perhaps the same evening you take the pen out of the fridge door before dinner) makes it far easier to stay on track. If you want to read more about how to pick that anchor day, our page on the best time to inject Mounjaro goes into this in more detail.
Yes, and the process is straightforward. If you need to shift your regular day (a holiday, a work trip, a routine that has changed) you can move the injection forward or back, provided the new dose falls at least four full days after the previous one. So if you normally inject on a Monday and want to switch to Thursday, the transition dose on that first Thursday is fine as long as Monday's injection was at least four days earlier.
One thing to be clear about: this is not a licence to take doses whenever convenient. The four-day minimum gap is a firm clinical boundary. Taking doses closer together than that is not recommended and should always be discussed with your prescriber first. The Mounjaro Patient Information Leaflet, which comes with every pen, sets this out plainly, read it before making any changes.
For more on whether the specific day of the week carries any clinical significance, the dedicated page on injecting Mounjaro on the same day every week covers the nuance further. If cost or access is a separate concern for you, a useful overview of the Eli Lilly UK price increase and what it means for patients is worth a read.
If you remember within four days of your missed dose, take it as soon as you remember and then resume your normal weekly schedule from that point. If more than four days have passed, skip the missed dose and wait for your next scheduled injection day. Under no circumstances should two doses be taken close together to compensate. The Mounjaro Summary of Product Characteristics on the eMC is the authoritative reference for missed-dose guidance, and your prescriber or pharmacist can clarify this for your specific situation.
It is also worth understanding that the titration schedule (starting at 2.5 mg, moving upward in steps at your prescriber's direction) is calibrated to reduce the likelihood of side effects like nausea. Timing irregularities rarely cause new symptoms, but if you notice that certain injection days consistently lead to more discomfort, mentioning this at your next clinical review is sensible. Our team at our clinical team takes these conversations seriously, getting your schedule right is part of the care, not an afterthought.
A couple, yes. First, storing the pen correctly is straightforward: Mounjaro must be kept refrigerated at 2–8°C, and the exact window for how long it can be kept at room temperature is detailed in the Patient Information Leaflet, always refer there rather than relying on a general figure. Second, rotating injection sites (abdomen, thigh, upper arm) independently of timing means that even if your injection day is consistent, you are not repeatedly using the same skin area. Our page on whether you can inject Mounjaro in the same spot explains why rotation matters clinically.
If you have not yet primed your pen before a dose, that is a separate practical step covered in detail on our priming guidance page. For a broader introduction to the injection itself (what to expect on the day) the Mounjaro injection guide is a clear starting point. And if you are thinking about starting treatment and want to understand eligibility, the free consultation is where that conversation begins with a GPhC-registered prescriber who reviews your answers personally.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.